Arcus Biosciences Inc (RCUS)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -283,000 | -307,000 | -267,000 | 53,000 | -123,000 |
| Revenue | US$ in thousands | 258,000 | 117,000 | 112,000 | 382,882 | 77,517 |
| Net profit margin | -109.69% | -262.39% | -238.39% | 13.84% | -158.67% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $-283,000K ÷ $258,000K
= -109.69%
Based on the provided data, the net profit margin of Arcus Biosciences Inc has exhibited significant fluctuations over the years. In December 2020, the company reported a negative net profit margin of -158.67%, indicating that it incurred a substantial loss relative to its revenue during that period.
By December 2021, the company's net profit margin improved significantly to 13.84%, suggesting that Arcus Biosciences Inc was able to generate a profit of approximately 13.84 cents for every dollar of revenue earned. However, the positive trend was short-lived as the net profit margin experienced a sharp decline to -238.39% by December 2022.
The profitability situation worsened in the subsequent years, with the net profit margin falling to -262.39% in December 2023 and further decreasing to -109.69% by December 2024. These negative figures indicate that the company's losses exceeded its revenue in those years, raising concerns about its financial performance and operational efficiency.
Overall, the fluctuating and predominantly negative net profit margins of Arcus Biosciences Inc underscore the challenges faced by the company in sustaining profitability and managing costs effectively during the specified period.
Peer comparison
Dec 31, 2024